Farmax India Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014
For the six months, the company's net sales/income from operations was INR 71.366 million compared to INR 87.06 million a year ago. Loss from operations before other income and exceptional items was INR 53.54 million compared to INR 66.11 million a year ago. Loss from ordinary activities before tax was INR 52.295 million compared to INR 64.34 million a year ago. Net loss was INR 52.295 million compared to INR 64.34 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.13 compared to INR 0.16 a year ago.